World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 28 April 2013
Main ID:  NTR890
Date of registration: 08/02/2007
Primary sponsor: Leiden University Medical Center (LUMC), Department of Pediatrics
Public title: Influence of the dietary history in the prevention of coeliac disease: possibilities of induction of tolerance for gluten in genetic predisposed children.
Scientific title: Influence of the dietary history in the prevention of coeliac disease: possibilities of induction of tolerance for gluten in genetic predisposed children. - PREVENTCD
Date of first enrolment: 1/1/2007
Target sample size: 1000
Recruitment status: complete
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=890
Study type:  intervention
Study design:  Randomised: Yes; Masking: Double; Control: Placebo; Group: Parallel; Type: [default]  
Countries of recruitment
The Netherlands
Contacts
Name: M.L.  Mearin
Address:  Leiden University Medical Centre Dept. Of Pediatrics PO box 9600 2300 RC Leiden The Netherlands
Telephone:
Email: M.L.Mearin_Manrique@lumc.nl
Affiliation: 
Name: M.L.  Mearin
Address:  Leiden University Medical Centre Dept. Of Pediatrics PO box 9600 2300 RC Leiden The Netherlands
Telephone:
Email: M.L.Mearin_Manrique@lumc.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1.Infant born during the study with a first degree relative (parent or sibling) with CD;
2.Informed consent for the study.

Exclusion criteria: 1. No informed consent;
2. Parents-guardians unable to understand the information necessary to give informed consent.


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Coeliac disease , Breastfeeding , Early feeding , Genetic predisposition , Human leukocyte antigen (HLA), Food intervention

Intervention(s)
In the family study:
1. The ?intervention group? will get a small amount of gluten (1 gram of wheat flour= 100mg gliadin) during the period of breastfeeding from the age of 4 months for 8 weeks.
2. The ?control group' (placebo) will get milk sugar powder (1gram of lactose) during the period of breastfeeding from the age of 4 months for 8 weeks.
Primary Outcome(s)
A reduction of 50% of CD among the intervention group at the age of 3 years will be considered as an effective prevention.
Secondary Outcome(s)
If the proposed early dietary intervention results in effective prevention of CD:
1. Development of new European guidelines for early nutrition in order to prevent the disease;
2. Identification of the influence of early feeding on the development of coeliac disease in relation with immunological and genetical factors.


Secondary ID(s)
ISRCTN74582487
N/A
Source(s) of Monetary Support
European Commission
Secondary Sponsor(s)
Children's Hospital Zagreb, Center for Paediatric Gastroenterology & Nutrition
Heim Pal Children's Hospital, Coeliakia Centrum
Hospital Univer.Infantil "La Paz"
Hospital Universitari de Sant Joan de Reus, Dept. of Paediatrics
Meyer Children' Hospital of Haifa, The Pediatric Gastroenterology and Nutrition Unit
Servico de Gastroenterologia Hospital Infantil, Universitario ?La Fe?
The Medical University of Warsaw, Dept. of Paediatric Gastroenterology & Nutrition
University of Naples, Federico II, Dept. of Pediatrics
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history